• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

A Prospective, randomized double-blind, placebo controlled study of safety and efficacy of HFSM-02 in reducing stress and anxiety in subjects with chronic medical condition and perceived stress

    Dr. Veena Deo , Bharatbhushan Shrikhande , Dr. Gayatri Ganu, Dr. Nilesh chandrawanshi .

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 2119-2129

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Objective: Stress is a feeling of emotional or physical tension. It has now become a part of modern lifestyle. At some point in life, everyone must have encountered with some degrees of stress. It has negative impact of life and certain complications associated which includes increased risk of cardiovascular disease, elevating certain medical conditions like asthma, diabetes, hypertension, etc. Considering the increasing prevalence of stress and anxiety through multiple factors, there is a great need to find a solution to the existing problem. The current research depicts the safety and efficacy of HFSM-02 in reducing stress and anxiety in subjects with chronic medical condition and perceived stress. Material and methods: 120 subjects were enrolled in the study. Subjects were undergoing clinical examination. Vitals were recorded. Blood samples were collected for biochemical tests like change in serum cortisol levels. Subjective questionnaire scores evaluation were performed like POMS-2, and GHQ-28, questionnaire. Changes in symptoms severity were noted like disturbed sleep, and day time mood swings.
Keywords:
    Diabetes POMS-2 stress Stress symptoms
  • PDF (346 K)
  • XML
(2021). A Prospective, randomized double-blind, placebo controlled study of safety and efficacy of HFSM-02 in reducing stress and anxiety in subjects with chronic medical condition and perceived stress. European Journal of Molecular & Clinical Medicine, 8(4), 2119-2129.
Dr. Veena Deo , Bharatbhushan Shrikhande , Dr. Gayatri Ganu, Dr. Nilesh chandrawanshi .. "A Prospective, randomized double-blind, placebo controlled study of safety and efficacy of HFSM-02 in reducing stress and anxiety in subjects with chronic medical condition and perceived stress". European Journal of Molecular & Clinical Medicine, 8, 4, 2021, 2119-2129.
(2021). 'A Prospective, randomized double-blind, placebo controlled study of safety and efficacy of HFSM-02 in reducing stress and anxiety in subjects with chronic medical condition and perceived stress', European Journal of Molecular & Clinical Medicine, 8(4), pp. 2119-2129.
A Prospective, randomized double-blind, placebo controlled study of safety and efficacy of HFSM-02 in reducing stress and anxiety in subjects with chronic medical condition and perceived stress. European Journal of Molecular & Clinical Medicine, 2021; 8(4): 2119-2129.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 108
  • PDF Download: 122
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus